Skip to main content

Advertisement

Log in

Preparation of cross-linked guar gum nanospheres containing tamoxifen citrate by single step emulsion in situ polymer cross-linking method

  • Original Article
  • Published:
Journal of Inclusion Phenomena and Macrocyclic Chemistry Aims and scope Submit manuscript

Abstract

In the present work, guar gum nanospheres containing tamoxifen citrate (TC) were prepared and characterized for using it as a carrier for targeted drug delivery. Tamoxifen is a non steroidal drug used in the treatment of breast cancer. The compound administered to patients is the citrate salt of the trans isomer, tamoxifen citrate. Single step emulsion in situ polymer crosslinking technique was employed to prepare polymer coated drug nanoparticles. Model polymer used in this study was guar gum, which is commonly used for colon specific drug delivery in the pharmaceutical industry. During preparation four-different drug loading solvents were tried and dichloromethane provided the best drug loading result. Briefly, 5 mg drug was dissolved in dichloromethane and emulsified with an aqueous solution of guar gum using span 80 as emulsifier. Cross-linking was made by the use of cross linker glutaraldehyde during the process. A core shell type particles were observed. Drug load was confirmed by FT-IR and quantitated by HPLC. Nanoparticles were further characterized for particle size and morphology. Particle size between 200 and 300 nm were obtained. Influence of process variables on the size of nanoparticles were studied. It was observed that the concentration of polymer and stabilizer determined the size of nanoparticles.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. O’Reagan, R.M., Jordan, V.C.: The evolution of tamoxifen therapy in breast cancer: selective oestrogen-receptor modulators and downregulators. Lancet Oncol. 3, 207–214 (2002). doi:10.1016/S1470-2045(02)00711-8

    Article  Google Scholar 

  2. Pappas, S.G., Jordan, V.C.: Chemoprevention of breast cancer: current and future prospects. Cancer Metastasis Rev. 21, 311–321 (2002). doi:10.1023/A:1021219212638

    Article  CAS  Google Scholar 

  3. Powles, T.J.: Anti-estrogenic chemoprevention of breast cancer—the need to progress. Eur. J. Cancer 39, 572–579 (2003). doi:10.1016/S0959-8049(02)00771-2

    Article  CAS  Google Scholar 

  4. Peters-Engl, C., Frank, W., Danmayr, E., Friedl, H.P., Leodolter, S., Medl, M.: Association between endometrial cancer and tamoxifen treatment of breast cancer. Breast Cancer Treat. 54, 255–260 (1999). doi:10.1023/A:1006126411210

    Article  CAS  Google Scholar 

  5. Cohen, I.: Endometrial pathologies associated with postmenopausal tamoxifen treatment. Gynecol. Oncol. 94, 256–266 (2004). doi:10.1016/j.ygyno.2004.03.048

    Article  CAS  Google Scholar 

  6. de Lima, G.R., Facina, G., Shida, J.Y., Chein, M.B.C., Tanaka, P., Dardes, R.C., Jordan, V.C., Gebrim, L.H.: Effects of low dose tamoxifen on normal breast tissue from premenopausal women. Eur J Cancer 39, 891–898 (2003). doi:10.1016/S0959-8049(02)00530-0

    Article  Google Scholar 

  7. Chawla, J.S., Amiji, M.M.: Biodegradable poly(e-caprolactone) nanoparticles for tumor targeted delivery of tamoxifen. Int. J. Pharm. 249, 127–138 (2002). doi:10.1016/S0378-5173(02)00483-0

    Article  CAS  Google Scholar 

  8. Brigger, I., Chaminade, P., Marsaud, V., Appel, M., Besnard, M., Gurny, R., Renoir, M., Couvreur, P.: Tamoxifen encapsulation within polyethylene glycol-coated nanospheres. Int. J. Pharm. 214, 37–42 (2001). doi:10.1016/S0378-5173(00)00628-1

    Article  CAS  Google Scholar 

  9. Chaurasia, M., Chaurasia, M.K., Jain, N.K., Jain, A., Gupta, Y., Jain, S.K.: Cross-linked guar gum microspheres: a viable approach for improved delivery of anticancer drugs for the treatment of colorectal cancer. AAPS PharmSciTech. 7(3), 74 (2006). doi:10.1208/pt070374

    Article  Google Scholar 

  10. Al-Saidan, S.M., Krishnaiah, Y.S.R., Satyanarayana, V., Bhaskar, P., Karthikeyan, R.S.: Pharmacokinetic evaluation of guar gum-based three-layer matrix tablets for oral controlled delivery of highly soluble metoprolol tartarate as a model drug. Eur. J. Pharm. Biopharm. 58, 697–703 (2004). doi:10.1016/j.ejpb.2004.04.013

    Article  CAS  Google Scholar 

  11. Sinha, V.R., Mittal, B.R., Kumria, R.: In vivo evaluation of time and site of disintegration of polysaccharide tablet prepared for colon-specific drug delivery. Int. J. Pharm. 289, 79–85 (2005). doi:10.1016/j.ijpharm.2004.10.019

    Article  CAS  Google Scholar 

  12. Labhasetwar, V., Song, C., Humphrey, W., Shebuski R.: J. Pharm. Sci. 87, 1229 (1998). doi:10.1021/js980021f

Download references

Acknowledgments

We thank the Centre for Central Instruments Facility at Indian Institute of Technology Guwahati (IITG) and acknowledge K. K. Senapati, Scientific Officer and Parikshit Gogoi, Technical Superintendent, Department of Chemistry, IITG for their support while carrying out analysis in Scanning Electron Microscope (SEM) and FT-IR.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rita Mahanta.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sarmah, J.K., Bhattacharjee, S.K., Mahanta, R. et al. Preparation of cross-linked guar gum nanospheres containing tamoxifen citrate by single step emulsion in situ polymer cross-linking method. J Incl Phenom Macrocycl Chem 65, 329–334 (2009). https://doi.org/10.1007/s10847-009-9589-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10847-009-9589-7

Keywords

Navigation